Wong, E. T., Rosenberg, H., Dawood, O., Hertan, L., Vega, R. A., Anderson, M., & Uhlmann, E. J. (2023). Lewy body disease as a potential negative outcome modifier of glioblastoma treatment: A case report. BMC Neurology, 23(1), 1. https://doi.org/10.1186/s12883-023-03313-4
Chicago Style (17th ed.) CitationWong, Eric T., Harry Rosenberg, Olivia Dawood, Lauren Hertan, Rafael A. Vega, Matthew Anderson, and Erik J. Uhlmann. "Lewy Body Disease as a Potential Negative Outcome Modifier of Glioblastoma Treatment: A Case Report." BMC Neurology 23, no. 1 (2023): 1. https://doi.org/10.1186/s12883-023-03313-4.
MLA (9th ed.) CitationWong, Eric T., et al. "Lewy Body Disease as a Potential Negative Outcome Modifier of Glioblastoma Treatment: A Case Report." BMC Neurology, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12883-023-03313-4.